Back to Journals » ClinicoEconomics and Outcomes Research » Volume 4

ClinicoEconomics and Outcomes Research

ISSN: 1178-6981


Archive: Volume 4, 2012

Cost and appropriateness of treating asthma with fixed-combination drugs in local health care units in Italy

Ruggeri I, Bragato D, Colombo GL, Valla E, Di Matteo S

ClinicoEconomics and Outcomes Research 2012, 4:375-382

Published Date: 5 December 2012

Budget impact analysis of boceprevir and telaprevir for the treatment of hepatitis C genotype 1 infection

Thorlund K, Druyts E, El Khoury AC, Mills EJ

ClinicoEconomics and Outcomes Research 2012, 4:349-359

Published Date: 16 November 2012

The impact of initial statin treatment decisions on cardiovascular outcomes in clinical care settings: estimates using the Archimedes Model

van Herick A, Schuetz CA, Alperin P, Bullano MF, Balu S, Gandhi S

ClinicoEconomics and Outcomes Research 2012, 4:337-347

Published Date: 9 November 2012

Economic analysis of Heart and Stroke Foundation of Ontario's Hypertension Management Initiative

de Oliveira C, Wijeysundera HC, Tobe SW, Moy Lum-Kwong M, Von Sychowski S, Wang X, Tu JV, Krahn MD

ClinicoEconomics and Outcomes Research 2012, 4:323-336

Published Date: 13 November 2012

Cost-effectiveness of candesartan versus losartan in the primary preventive treatment of hypertension

Granström O, Levin LA, Henriksson M

ClinicoEconomics and Outcomes Research 2012, 4:313-322

Published Date: 1 November 2012

Impact of dry eye on work productivity

Yamada M, Mizuno Y, Shigeyasu C

ClinicoEconomics and Outcomes Research 2012, 4:307-312

Published Date: 10 October 2012

Maintenance erlotinib in advanced nonsmall cell lung cancer: cost-effectiveness in EGFR wild-type across Europe

Walleser S, Ray J, Bischoff H, Vergnenègre A, Rosery H, Chouaid C, Heigener D, de Castro Carpeño J, Tiseo M, Walzer S

ClinicoEconomics and Outcomes Research 2012, 4:269-275

Published Date: 14 September 2012

Budget impact analysis of two immunotherapy products for treatment of grass pollen-induced allergic rhinoconjunctivitis

Rønborg SM, Svendsen UG, Micheelsen JS, Ytte L, Andreasen JN, Ehlers L

ClinicoEconomics and Outcomes Research 2012, 4:253-260

Published Date: 11 September 2012

Cost of human immunodeficiency virus infection in Italy, 2007–2009: effective and expensive, are the new drugs worthwhile?

Rizzardini G, Restelli U, Bonfanti P, Porazzi E, Ricci E, Foglia E, Carenzi L, Croce D

ClinicoEconomics and Outcomes Research 2012, 4:245-252

Published Date: 5 September 2012

Cost comparison of second-line treatment options for late stage non-small-cell lung cancer: cost analysis for Italy

Schwander B, Ravera S, Giuliani G, Nuijten M, Walzer S

ClinicoEconomics and Outcomes Research 2012, 4:237-243

Published Date: 3 September 2012

Cost-effectiveness of entecavir versus adefovir for the treatment of chronic hepatitis B in patients with decompensated cirrhosis from a third-party US payer perspective

Tsai N, Jeffers L, Cragin L, Sorensen S, Su W, Rosenblatt L, Tang H, Hebden T, Juday T

ClinicoEconomics and Outcomes Research 2012, 4:227-235

Published Date: 23 August 2012

Cost of rheumatoid arthritis in a selected population from Argentina in the prebiologic therapy era

Catay E, Castel del Cid C, Narváez L, Velozo EJ, Rosa JE, Catoggio LJ, Soriano ER

ClinicoEconomics and Outcomes Research 2012, 4:219-225

Published Date: 23 August 2012

Burden of Crohn’s disease: economics and quality of life aspects in Italy

Benedini V, Caporaso N, Corazza GR, Rossi Z, Fornaciari G, Cottone M, Frosini G, Caruggi M, Ottolini C, Colombo GL

ClinicoEconomics and Outcomes Research 2012, 4:209-218

Published Date: 24 July 2012

Economic evaluation of alternative assisted reproduction techniques in management of infertility in Greece

Fragoulakis V, Kourlaba G, Tarlatzis B, Mastrominas M, Maniadakis N

ClinicoEconomics and Outcomes Research 2012, 4:185-192

Published Date: 12 July 2012

Techniques for estimating health care costs with censored data: an overview for the health services researcher

Wijeysundera HC, Wang X, Tomlinson G, Ko DT, Krahn MD

ClinicoEconomics and Outcomes Research 2012, 4:145-155

Published Date: 1 June 2012

Economic evaluation of intravenous iron treatments in the management of anemia patients in Greece

Fragoulakis V, Kourlaba G, Goumenos D, Konstantoulakis M, Maniadakis N

ClinicoEconomics and Outcomes Research 2012, 4:127-134

Published Date: 4 May 2012

Forecast model for the evaluation of economic resources employed in the health care of patients with HIV infection

Sacchi P, Patruno SFA, Bruno R, Cima SMB, Previtali P, Franchini A, Nicolini L, Rognoni C, Sacchi L, Bellazzi R, Filice G

ClinicoEconomics and Outcomes Research 2012, 4:117-126

Published Date: 11 May 2012

Cost-effectiveness study of oral hypoglycemic agents in the treatment of outpatients with type 2 diabetes attending a public primary care clinic in Mexico City

Díaz de León-Castañeda C, Altagracia-Martínez M, Kravzov-Jinich J, Cárdenas-Elizalde MR, Moreno-Bonett C, Martínez-Núñez JM

ClinicoEconomics and Outcomes Research 2012, 4:57-65

Published Date: 7 March 2012

Treatment profiles and costs of patients with chronic pain in the population setting

Sicras Mainar A, Navarro Artieda R, Villoria Morillo J, Esquivias Escobar A

ClinicoEconomics and Outcomes Research 2012, 4:39-47

Published Date: 26 January 2012

Cross-market cost-effectiveness analysis of erlotinib as first-line maintenance treatment for patients with stable non-small cell lung cancer

Vergnenègre A, Ray JA, Chouaid C, Grossi F, Bischoff HG, Heigener DF, Walzer S

ClinicoEconomics and Outcomes Research 2012, 4:31-37

Published Date: 26 January 2012

Health status, hospitalizations, day procedures, and physician costs associated with body mass index (BMI) levels in Ontario, Canada

Tarride JE, Haq M, Taylor VH, Sharma AM, Nakhai-Pour HR,  O'Reilly D, Xie F, Dolovich L, Goeree R

ClinicoEconomics and Outcomes Research 2012, 4:21-30

Published Date: 24 January 2012

Predictors of antipsychotic monotherapy with olanzapine during a 1-year naturalistic study of schizophrenia patients in Japan

Ye W, Ascher-Svanum H, Flynn JA, Tanji Y, Takahashi M

ClinicoEconomics and Outcomes Research 2012, 4:13-19

Published Date: 13 January 2012